Mostrar el registro sencillo del ítem

dc.contributor.author
Bregonzio Diaz, Claudia  
dc.date.available
2025-03-12T11:21:23Z  
dc.date.issued
2023-07  
dc.identifier.citation
Bregonzio Diaz, Claudia; Metabolic syndrome as a risk for Parkinson’s disease: A new therapeutic opportunity; Academic Press Inc Elsevier Science; Brain Behavior And Immunity; 111; 7-2023; 125-126  
dc.identifier.issn
0889-1591  
dc.identifier.uri
http://hdl.handle.net/11336/255997  
dc.description.abstract
Metabolic syndrome (MetS) and Parkinson’s disease (PD) are related but their mechanistic links are unknown. To explore this, Pedrosa et al. have performed an interesting and exhaustive study to reveal whether AT1 receptor autoantibodies (AT1-AA, with agonistic effect on AT1 receptors) and angiotensin converting enzyme 2 autoantibodies (ACE2-AA, antagonists on ACE2) are increased in MetS, and whether these autoantibodies may mediate a possible enhancing effect of MetS on dopaminergic cell death and PD (Pedrosa et al., 2023)...  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Academic Press Inc Elsevier Science  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
DOPAMINERGIC VULNERABILITY  
dc.subject
HYPERTENSION  
dc.subject
DIABETES  
dc.subject
AT1 RECEPTORS AUTOANTIBODIES  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Metabolic syndrome as a risk for Parkinson’s disease: A new therapeutic opportunity  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2025-03-07T12:39:56Z  
dc.journal.volume
111  
dc.journal.pagination
125-126  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Bregonzio Diaz, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Farmacología Experimental de Córdoba. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Instituto de Farmacología Experimental de Córdoba; Argentina  
dc.journal.title
Brain Behavior And Immunity  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0889159123000879  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bbi.2023.03.030  

Archivos asociados
Tamaño: 272.5Kb
Formato: PDF
.